Vestal Point Capital as of Dec. 31, 2024
Portfolio Holdings for Vestal Point Capital
Vestal Point Capital holds 73 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.1 | $120M | 975k | 123.15 | |
| Cytokinetics Com New (CYTK) | 6.6 | $111M | 2.4M | 47.04 | |
| Merck & Co (MRK) | 4.7 | $80M | 800k | 99.48 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 4.2 | $72M | 520k | 137.67 | |
| Ultragenyx Pharmaceutical (RARE) | 3.7 | $63M | 1.5M | 42.07 | |
| Insmed Com Par $.01 (INSM) | 3.7 | $62M | 900k | 69.04 | |
| BioMarin Pharmaceutical (BMRN) | 3.4 | $57M | 860k | 65.73 | |
| uniQure NV SHS (QURE) | 3.2 | $53M | 3.0M | 17.66 | |
| Soleno Therapeutics (SLNO) | 2.8 | $48M | 1.1M | 44.95 | |
| Nuvalent Inc-a (NUVL) | 2.8 | $47M | 600k | 78.28 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.8 | $47M | 1.7M | 27.12 | |
| Vera Therapeutics Cl A (VERA) | 2.7 | $46M | 1.1M | 42.29 | |
| Immatics NV SHS (IMTX) | 2.6 | $45M | 6.3M | 7.11 | |
| Kalvista Pharmaceuticals (KALV) | 2.4 | $40M | 4.8M | 8.47 | |
| Geron Corporation (GERN) | 2.3 | $39M | 11M | 3.54 | |
| Astria Therapeutics (ATXS) | 2.2 | $37M | 4.2M | 8.94 | |
| Arcellx Common Stock (ACLX) | 2.2 | $36M | 475k | 76.69 | |
| Sanofi SA Sponsored Adr (SNY) | 2.1 | $36M | 750k | 48.23 | |
| GSK Sponsored Adr (GSK) | 2.0 | $34M | 1.0M | 33.82 | |
| Savara (SVRA) | 2.0 | $33M | 11M | 3.07 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $32M | 810k | 39.20 | |
| Amicus Therapeutics (FOLD) | 1.9 | $32M | 3.4M | 9.42 | |
| AstraZeneca Sponsored Adr (AZN) | 1.8 | $31M | 475k | 65.52 | |
| Sarepta Therapeutics (SRPT) | 1.8 | $30M | 250k | 121.59 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $29M | 95k | 308.57 | |
| Globus Medical Cl A (GMED) | 1.6 | $27M | 325k | 82.71 | |
| Dianthus Therapeutics (DNTH) | 1.4 | $23M | 1.1M | 21.80 | |
| Nyxoah SA SHS (NYXH) | 1.4 | $23M | 2.9M | 8.00 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.4 | $23M | 495k | 46.44 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $21M | 595k | 34.96 | |
| Liquidia Corp Com New (LQDA) | 1.2 | $21M | 1.8M | 11.76 | |
| Day One Biopharmaceuticals I (DAWN) | 1.1 | $18M | 1.4M | 12.67 | |
| Urogen Pharma (URGN) | 1.0 | $17M | 1.6M | 10.65 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $16M | 475k | 32.54 | |
| Roivant Sciences SHS (ROIV) | 0.9 | $15M | 1.3M | 11.83 | |
| Regeneron Pharmaceuticals (REGN) | 0.8 | $14M | 20k | 712.33 | |
| Establishment Labs Holdings Ord (ESTA) | 0.8 | $14M | 300k | 46.07 | |
| Tyra Biosciences (TYRA) | 0.8 | $14M | 990k | 13.90 | |
| Bicara Therapeutics (BCAX) | 0.7 | $12M | 710k | 17.42 | |
| Black Diamond Therapeutics (BDTX) | 0.7 | $12M | 5.6M | 2.14 | |
| Solid Biosciences Com New (SLDB) | 0.7 | $11M | 2.9M | 4.00 | |
| Agilent Technologies Inc C ommon (A) | 0.6 | $10M | 75k | 134.34 | |
| Applied Therapeutics (APLT) | 0.6 | $9.8M | 12M | 0.86 | |
| Perrigo SHS (PRGO) | 0.6 | $9.6M | 375k | 25.71 | |
| Nurix Therapeutics (NRIX) | 0.5 | $9.1M | 485k | 18.84 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $7.9M | 1.2M | 6.58 | |
| Zai Lab Adr (ZLAB) | 0.5 | $7.9M | 300k | 26.19 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $7.7M | 305k | 25.27 | |
| Voyager Therapeutics (VYGR) | 0.4 | $7.0M | 1.2M | 5.67 | |
| Iteos Therapeutics | 0.4 | $6.9M | 900k | 7.68 | |
| Intellia Therapeutics (NTLA) | 0.4 | $6.1M | 525k | 11.66 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.3 | $5.5M | 635k | 8.60 | |
| Galapagos NV Spon Adr (GLPG) | 0.3 | $5.0M | 180k | 27.50 | |
| Chimerix (CMRX) | 0.3 | $4.9M | 1.4M | 3.48 | |
| Sutro Biopharma (STRO) | 0.3 | $4.7M | 2.6M | 1.84 | |
| Ventyx Biosciences (VTYX) | 0.3 | $4.4M | 2.0M | 2.19 | |
| Fate Therapeutics (FATE) | 0.2 | $4.1M | 2.5M | 1.65 | |
| Alto Neuroscience Com Shs (ANRO) | 0.2 | $3.9M | 915k | 4.23 | |
| Verve Therapeutics (VERV) | 0.2 | $3.6M | 645k | 5.64 | |
| Passage Bio | 0.2 | $3.5M | 6.1M | 0.57 | |
| Allogene Therapeutics (ALLO) | 0.2 | $3.2M | 1.5M | 2.13 | |
| Transmedics Group (TMDX) | 0.2 | $3.1M | 50k | 62.35 | |
| Monte Rosa Therapeutics (GLUE) | 0.2 | $2.9M | 425k | 6.94 | |
| Zymeworks Del (ZYME) | 0.2 | $2.7M | 185k | 14.64 | |
| Engene Holdings (ENGN) | 0.1 | $2.5M | 370k | 6.65 | |
| Bausch Health Companies (BHC) | 0.1 | $2.0M | 250k | 8.06 | |
| Neurogene (NGNE) | 0.1 | $1.8M | 80k | 22.86 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.7M | 1.5M | 1.14 | |
| Atara Biotherapeutics Com New (ATRA) | 0.1 | $1.7M | 125k | 13.31 | |
| Immunovant (IMVT) | 0.1 | $1.1M | 45k | 24.77 | |
| Macrogenics (MGNX) | 0.1 | $910k | 280k | 3.25 | |
| Traws Pharma Com New (TRAW) | 0.0 | $666k | 75k | 8.88 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $342k | 55k | 6.19 |